Washington
+919359902383
+919359902383

Bulk Oncology Medicine Exporter to USA | Sunixar 12.5mg Wholesale | Ernest Impex

Sunixar 12.5 mg Capsule: Targeted Multi-Kinase Inhibition for Advanced Oncology Management



Are you searching for a reliable Sunixar 12.5 mg capsule exporter from IndiaErnest Impex, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced targeted therapies. We maintain an agile and secure supply chain for Washington, London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity.





Detailed Product Profile: What is Sunixar 12.5mg?


Sunixar 12.5 mg is an oral targeted therapy containing the active pharmaceutical ingredient Sunitinib. Manufactured by Sun Pharmaceutical Industries Ltd., this 12.5mg capsule is a potent multi-kinase inhibitor. It is specifically designed to interfere with the signaling pathways that cancer cells use to grow, divide, and develop the blood vessels necessary for tumor survival.



1. Therapeutic Indications


Sunixar 12.5 mg is clinically utilized globally for the treatment of

  • Renal Cell Carcinoma (RCC): Indicated for the treatment of advanced or metastatic kidney cancer. It is also used as an adjuvant treatment for patients at high risk of recurrent RCC following surgery.

  • Gastrointestinal Stromal Tumors (GIST): Specifically for patients whose disease has progressed or who are intolerant to Imatinib therapy.

  • Pancreatic Neuroendocrine Tumors (pNET): Used to treat progressive, well-differentiated pNET in patients with unresectable, locally advanced, or metastatic disease.

2. Mechanism of Action: Dual-Pathway Attack

Sunixar works through a sophisticated mechanism known as Multi-Tyrosine Kinase Inhibition:

  • Anti-Angiogenic Effect: It inhibits Vascular Endothelial Growth Factor Receptors (VEGFR) and Platelet-Derived Growth Factor Receptors (PDGFR). This "starves" the tumor by blocking the formation of new blood vessels that provide oxygen and nutrients.

  • Direct Anti-Tumor Activity: By blocking receptors like KIT and FLT3, Sunixar interrupts the growth signals sent to cancer cells, slowing or stopping their proliferation.

  • Metastasis Prevention: By disrupting these signaling pathways, it helps contain the cancer and prevents malignant cells from invading other tissues.

3. Administration and Cycle Management

  • Standard Dosing: For RCC and GIST, it is often prescribed in a "4 weeks on, 2 weeks off" cycle (Schedule 4/2). For pNET, it is typically administered as a continuous daily dose.

  • Timing: Can be taken with or without food. Capsules must be swallowed whole.

  • Flexibility: The 12.5mg strength is essential for precise dose titration and management of patient-specific responses.




Clinical Side Effects & Safety Monitoring


Patients on Sunixar 12.5 mg require vigilant medical supervision for the following:

  • Hematological Safety: Potential for Neutropenia (low white blood cells) and Thrombocytopenia (low platelets). Regular blood counts are mandatory.

  • Cardiovascular Monitoring: High blood pressure (Hypertension) is a common side effect; patients should also be monitored for signs of heart failure or QT interval prolongation.

  • Hepatotoxicity: Rare but serious liver failure; liver function tests (LFTs) must be performed periodically.

  • Hand-Foot Syndrome: Skin reactions such as redness, pain, or blisters on the palms and soles.

  • Thyroid Function: Potential for hypothyroidism, requiring routine thyroid-stimulating hormone (TSH) checks.


Why Source Sunixar 12.5 mg from Ernest Impex?


In 2026, international pharmaceutical procurement demands Supply Chain Resilience and Direct Traceability. Ernest Impex offers:

  • Verified Authenticity: Direct sourcing of Sun Pharma’s Sunixar with full batch-specific COA and traceability.

  • Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Thailand, Australia, Singapore, and Jamaica.

  • Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors.

  • Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards.


πŸ“ž Contact Ernest Impex β€” Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Websites:


πŸ“§ Email: exports@ernestpharmaceuticals.com

πŸ“¦ Business Type: Exporter | Bulk Supplier | Distributor

 πŸ“² WhatsApp: +91 93599 02383 

πŸ”— Direct Link: Chat on WhatsApp

 2026-04-28T09:30:40

Keywords